Coherus Oncology, Inc. (CHRS) dividend history
CHRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3059% below fair value
$0.48−0.03 (-5.42%)
Close on Nov 17, 2026Market cap $73.93MP/E –Yield –
Dividends
Coherus Oncology has not reported a dividend
No dividend per share appears in Coherus Oncology's annual filings since fiscal 2011.
See a number that looks wrong?